Shyam Metalics and Energy key Products/Revenue Segments include Steel, Sale of services, Export Incentives, Power, Miscellaneous, Other Operating Revenue for the year ending 31-Mar-2022.

Current valuation at 2x/1.8x for FY23E / FY24E P/EV is attractive.

Balkrishna Industries, incorporated in the year 1961, is a Large Cap company (having a market cap of Rs 42879.69 Crore) operating in Tyres sector.

Hatsun Agro Products, incorporated in the year 1986, is a Mid Cap company (having a market cap of Rs 19111.84 Crore) operating in FMCG sector.

The brokerage values the stock at ~36x 1-year forward EV/EBITDA.

Promoters held 16.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 42.0 per cent, DIIs 24.94 per cent.

Key downside risks are delayed recovery in demand, sustained raw material inflation and irrational competition.

Lower-than-expected urban recovery and potential execution challenges in new categories are key risks.

The brokerage upgrades the stock to ADD with an unchanged target price of Rs 700, valuing it at 3.5x FY24E BVPS.

With sustained move above important moving averages, the stock is expected to travel north.

Bullish flag breakout and sustaining above 13 days EMA signaling further upward momentum.

Price resuming up after forming a base above the recent breakout area and 20 days EMA, signaling continuation of up move.

Consolidation above Rs 370 is in a mature phase, positive follow-up action could lift the stock till Rs 405 zone.

Stock rebounded off the support zone. Break above Rs 530 could unlock upside potential till Rs 570.

Maintaining a positive outlook on the company’s long-term performance, the brokerage retains its BUY rating on the stock with a rolled forward target price of Rs 110 based on 1.1x FY25E BVPS.

Global Health, incorporated in the year 2004, is a Small Cap company (having a market cap of Rs 11970.43 Crore) operating in General sector.

The company's performance with regard to outstanding restructured assets, write-offs have been relatively better than peers and the brokerage expects the same to sustain given its stringent underwriting practices.

JM Financial expects stock to rerate upwards aided by steady delivery on growth and return metrics.

The brokerage values the company at 1.8x FY25E EV to arrive at its target price of Rs 600.

Promoters held 62.94 per cent stake in the company as of 31-Dec-2022, while FIIs owned 4.15 per cent, DIIs 15.45 per cent.